FDA Approved: CELEBREX — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for Celebrex (celecoxib) submitted by Viatris Specialty LLC to update the product labeling under NDA 020998.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dysmenorrhea
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

SUPPL AP for CELEBREX (CELECOXIB)